3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Unknown
1
Recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
4
Sarcoma
2
Meningioma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms
1
Ion Beam Radiation Therapy for Tumor Patients
1
Gastroesophageal Junction Adenocarcinoma
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Protons
×
Clear all
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled